Form 4: Precipio Director Jeffrey Cossman Receives Stock Options

Precipio, Inc. Director Jeffrey Cossman was granted 1,500 stock options with an exercise price of $23.82 per share, vesting monthly over one year.

Summary

• Jeffrey Cossman, a Director of Precipio, Inc. (PRPO), was granted 1,500 stock options.
• The transaction date for this grant was January 2, 2026.
• Each option has an exercise price of $23.82 per share.
• The options will vest in twelve equal monthly installments, starting one month after the issuance date.
• The expiration date for these stock options is January 2, 2036.
• The grant was made under the Issuer's Equity Incentive Plan as compensation for Mr. Cossman's service as a director.

Sentiment

Score: 6

Explanation: The filing reports a routine compensation event for a director, which is generally neutral but slightly positive due to increased alignment of interests. It does not contain information that would significantly alter the company's fundamental outlook.

Positives

• The grant of stock options aligns the interests of Director Jeffrey Cossman with those of shareholders, as the options gain value if the stock price increases above the exercise price.
• The options were granted as compensation for service, indicating continued engagement of a director.

Negatives

• Potential for future dilution if the options are exercised, although the amount is relatively small (1,500 shares).

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports an insider's transaction.

Management Comments

• The stock option was granted pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer.

Industry Context

The grant of stock options to directors is a common practice in publicly traded companies, serving as a form of equity-based compensation to attract and retain talent and align their interests with long-term shareholder value creation.

Comparison to Industry Standards

• Granting stock options as part of director compensation is a standard practice across various industries, including biotechnology and diagnostics, where Precipio operates.
• The specific number of options (1,500) and exercise price ($23.82) would typically be benchmarked against peer companies of similar market capitalization and stage of development, though this filing does not provide such comparative data.
• The vesting schedule of twelve equal monthly installments over one year is a common approach to encourage continued service.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential minor future dilution if options are exercised, but also increased alignment of director interests with shareholder value.

Next Steps

• The stock options will begin vesting in twelve equal monthly installments starting one month after January 2, 2026.

Key Dates

Recommendation

This Form 4 filing details a routine grant of stock options to an existing director as part of their compensation. Such a transaction is not typically considered a material event that would significantly impact the company's valuation or warrant a change in investment recommendation. It primarily serves to align the director's interests with long-term shareholder value.

Keywords

Precipio, PRPO, stock options, director compensation, Form 4, insider transaction, equity incentive plan, Jeffrey Cossman